Gwangju-si, South Korea

Soo Kyung Jung

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Soo Kyung Jung: Innovator in Stem Cell Research

Introduction

Soo Kyung Jung is a prominent inventor based in Gwangju-si, South Korea. He has made significant contributions to the field of stem cell research, particularly in the development of methods for preparing mesenchymal stem cells. His innovative approach has the potential to advance cell therapy products and improve treatment outcomes.

Latest Patents

Soo Kyung Jung holds a patent titled "Medium for direct differentiation of pluripotent stem cell-derived mesenchymal stem cell, method for preparing mesenchymal stem cell by using same, and mesenchymal stem cell prepared thereby." This patent describes a medium composition and method that allows for the direct differentiation of embryonic stem cell-derived mesenchymal stem cells. The method enables the preparation of mesenchymal stem cells at high yield within a short period of time. Additionally, it simplifies the preparation procedure by eliminating the embryoid body formation step, resulting in homogeneous cells and a quicker production of cell therapy products compared to conventional methods.

Career Highlights

Soo Kyung Jung is associated with Cha Biotech Co., Ltd., where he continues to work on innovative solutions in the field of biotechnology. His research focuses on enhancing the efficiency and effectiveness of stem cell therapies, which are crucial for various medical applications.

Collaborations

He collaborates with notable colleagues, including Dong Ryul Lee and Jeong Eun Lee, who contribute to his research endeavors and help advance the field of stem cell technology.

Conclusion

Soo Kyung Jung's work in stem cell research exemplifies the impact of innovation in biotechnology. His patented methods and ongoing research efforts are paving the way for advancements in cell therapy, ultimately benefiting patients in need of effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…